期刊论文详细信息
| Biomedicinska istraživanja | |
| Neoadjuvant therapy for HER2-positive breast cancer | |
| Zdenka Gojković1  Nikolina Dukić2  Olivera Čančar3  Srdjan Mašić3  Jelena Vladičić-Mašić3  Sladjana Popović3  Dragana Jokanović3  Nenad Lalović3  | |
| [1] University Clinical Center of the Republic Srpska, Clinics in Oncology, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina;University Hospital Foča, Center for Internal Medicine, The Republic of Srpska, Bosnia and Herzegovina;University of East Sarajevo, The Faculty of Medicine, Foča, The Republic of Srpska, Bosnia and Herzegovina; | |
| 关键词: breast carcer; HER2 receptor; neoadjuvant therapy; pCR; trastuzumab; pertuzumab; | |
| DOI : doi:10.7251/BII1901083D | |
| 来源: DOAJ | |
【 授权许可】
Unknown